Should aspirin be continued in patients started on warfarin?

Area of Science:

• Cardiology
• Pharmacology
• Clinical Medicine

Background:

• Clinicians often decide whether to continue aspirin when initiating warfarin therapy.
• This decision involves balancing risks of bleeding against benefits of preventing thromboembolic events.
• A meta-analysis was conducted to evaluate these tradeoffs.

Purpose of the Study:

• To characterize the benefits and risks of combining aspirin with warfarin.
• To provide evidence-based guidance for clinicians managing patients on warfarin therapy.

Main Methods:

• A meta-analysis of randomized controlled trials comparing warfarin plus aspirin versus warfarin alone was performed.
• Studies published between 1966 and 2003 were identified through multiple databases, reference lists, and author queries.
• Data on thromboembolism, hemorrhage, and all-cause mortality were extracted and synthesized.

Main Results:

• Nine studies met the inclusion criteria.
• For mechanical heart valve patients, combination therapy significantly reduced thromboembolic events (RR 0.33) and all-cause mortality (RR 0.43) but increased major bleeding (RR 1.58).
• Results varied based on target international normalized ratio (INR) and patient population, with insufficient data for other indications.

Conclusions:

• Continuing aspirin with warfarin is beneficial for mechanical heart valve patients, despite increased bleeding risk.
• Current data are inadequate to guide the use of aspirin with warfarin for other common indications.
• Further research is needed to clarify optimal anticoagulation strategies for diverse patient groups.